Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds

Index by author

September 1, 1997; Volume 38,Issue 9
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z

  1. Gallowitsch, H. J.

    1. You have access
      MIBI and Thyroid Tumors
      E. Kresnik, H. J. Gallowitsch, P. Mikosch and P. Lind
      Journal of Nuclear Medicine September 1, 1997, 38 (9) 1501;
  2. Gamelin, Erik

    1. You have access
      Predicting the Efficacy of First Iodine-131 Treatment in Differentiated Thyroid Carcinoma
      Jean-Pierre Muratet, Philippe Giraud, Alain Daver, Jean-François Minier, Erik Gamelin and Francis Larra
      Journal of Nuclear Medicine September 1, 1997, 38 (9) 1362-1368;
  3. Gansauge, Frank

    1. You have access
      Overexpression of Glucose Transporter 1 and Increased FDG Uptake in Pancreatic Carcinoma
      Sven N. Reske, Kurt G. Grillenberger, Gerhard Glatting, Matthias Port, Martin Hildebrandt, Frank Gansauge and Hans-Günther Beger
      Journal of Nuclear Medicine September 1, 1997, 38 (9) 1344-1348;
  4. Germano, Guido

    1. You have access
      Clinical Validation of Automatic Quantitative Defect Size in Rest Technetium-99m-Sestamibi Myocardial Perfusion SPECT
      Xingping Kang, Daniel S. Berman, Kenneth F. Van Train, Aman M. Amanullah, Joseph Areeda, John D. Friedman, Hosen Kiat and Guido Germano
      Journal of Nuclear Medicine September 1, 1997, 38 (9) 1441-1446;
  5. Ghazzar, Nadia

    1. You have access
      Specificity of Radioiodinated MIBG for Neural Crest Tumors in Childhood
      Ann Leung, Brahm Shapiro, Robert Hattner, Esther Kim, Jan de Kraker, Nadia Ghazzar, Olivier Hartmann, Cornelius A. Hoefnagel, David A. Jamadar, Richard Kloos, Paul Lizotte, Jean Lumbroso, Vittoria Rufini, Barry L. Shulkin, James C. Sisson, Aung Thein and Luigi Troncone
      Journal of Nuclear Medicine September 1, 1997, 38 (9) 1352-1357;
  6. Giraud, Philippe

    1. You have access
      Predicting the Efficacy of First Iodine-131 Treatment in Differentiated Thyroid Carcinoma
      Jean-Pierre Muratet, Philippe Giraud, Alain Daver, Jean-François Minier, Erik Gamelin and Francis Larra
      Journal of Nuclear Medicine September 1, 1997, 38 (9) 1362-1368;
  7. Glatting, Gerhard

    1. You have access
      Overexpression of Glucose Transporter 1 and Increased FDG Uptake in Pancreatic Carcinoma
      Sven N. Reske, Kurt G. Grillenberger, Gerhard Glatting, Matthias Port, Martin Hildebrandt, Frank Gansauge and Hans-Günther Beger
      Journal of Nuclear Medicine September 1, 1997, 38 (9) 1344-1348;
  8. Go, Raymundo T.

    1. You have access
      Viable Neurons with Luxury Perfusion in Hydrocephalus
      Ching-yee Oliver Wong, Mark G. Luciano, William J. MacIntyre, Richard C. Brunken, Joseph F. Hahn and Raymundo T. Go
      Journal of Nuclear Medicine September 1, 1997, 38 (9) 1467-1470;
  9. Goldenberg, David M.

    1. You have access
      Manipulation of Blood Clearance to Optimize Delivery of Residualizing Label-Antibody Conjugates to Tumor Cells In Vivo
      Rhona Stein, David M. Goldenberg, Gaik Lin Ong, Suzanne R. Thorpe and M. Jules Mattes
      Journal of Nuclear Medicine September 1, 1997, 38 (9) 1392-1400;
  10. Goldman, Serge

    1. You have access
      Regional Methionine and Glucose Uptake in High-Grade Gliomas: A Comparative Study on PET-Guided Stereotactic Biopsy
      Serge Goldman, Marc Levivier, Benoît Pirotte, Jean-Marie Brucher, David Wikler, Philippe Damhaut, Sophie Dethy, Jacques Brotchi and Jerzy Hildebrand
      Journal of Nuclear Medicine September 1, 1997, 38 (9) 1459-1462;
« Previous (Pages : 1 2 ... 2) Next »
Back to top
PreviousNext

In this issue

Journal of Nuclear Medicine
Vol. 38, Issue 9
September 1, 1997
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Advertising (PDF)
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Sign up for alerts
  • Most Cited
  • Most Read
Loading
  • MIRD Pamphlet No. 28, Part 1: MIRDcalc—A Software Tool for Medical Internal Radiation Dosimetry
  • Absorbed Dose–Response Relationship in Patients with Gastroenteropancreatic Neuroendocrine Tumors Treated with [177Lu]Lu-DOTATATE: One Step Closer to Personalized Medicine
  • Prediction of 177Lu-DOTATATE PRRT Outcome Using Multimodality Imaging in Patients with Gastroenteropancreatic Neuroendocrine Tumors: Results from a Prospective Phase II LUMEN Study
  • Renal and Multiorgan Safety of 177Lu-PSMA-617 in Patients with Metastatic Castration-Resistant Prostate Cancer in the VISION Dosimetry Substudy
  • High-Temporal-Resolution Lung Kinetic Modeling Using Total-Body Dynamic PET with Time-Delay and Dispersion Corrections
More...
SNMMI

© 2025 SNMMI

Powered by HighWire